Recursion Pharmaceuticals Stock (NASDAQ: RXRX) stock price, news, charts, stock research, profile.
You can purchase shares of Recursion Pharmaceuticals (NASDAQ:RXRX) through any online brokerage.
Other companies in Recursion Pharmaceuticals’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS) and Ascentage Pharma Group (NASDAQ:AAPG).
Recursion Pharmaceuticals has a consensus price target of $11.78.
The stock price for Recursion Pharmaceuticals (NASDAQ: RXRX) is $9.32 last updated February 21, 2025 at 7:59 PM EST.
There are no upcoming dividends for Recursion Pharmaceuticals.
Recursion Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for Recursion Pharmaceuticals.
Recursion Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.